← Leaderboards
William J Britt
University Of Alabama At Birmingham
$28,989,956
Attributed
$36,386,915
Total exposure
22
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,356,647 · 23
By mechanism
R01$31,512,477 · 10
U01$4,240,259 · 2
P30$2,383,627 · 3
P01$998,208 · 2
R21$555,500 · 2
R56$468,660 · 2
Top collaborators
- Michael Mach7 shared
- Keiko Hirose6 shared
- Stipan Jonjic6 shared
- Marisa Marcia Mussi-Pinhata6 shared
- Suresh B Boppana5 shared
- Jay A Nelson5 shared
- Swetha Geetha Pinninti5 shared
- Charles E Mckenna1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Robert Floyd Pass$10,874,670
- Suresh B Boppana$9,522,148
- Swetha Geetha Pinninti$90,176
- Gail Wiliams Wertz$7,689,443
- Phillip D Smith$9,904,380
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusVirusViralInfectionCytomegalovirus InfectionsVirus DiseasesComplexCellsLeadVaccinesInfantSecondary ToImmunityResponseImmune ResponsePathway InteractionsDesignVirionVirus ReplicationAntiviral AgentsAntibodiesProteinsChildHearing Impairment
Grant awards (113)
Tegument Envelope Protein Interactions in CMV Envelopment$466,698
R01 · FY2025 · AI · contact PI
Tegument Envelope Protein Interactions in CMV Envelopment$481,131
R01 · FY2024 · AI · contact PI
Adaptive Immunity and Persistent SARS-CoV-2 Replication$1,512,103
U01 · FY2023 · CA
CMV Vaccines: Reinfection and Antigenic Variation$502,963
R01 · FY2023 · HD · contact PI
Tegument Envelope Protein Interactions in CMV Envelopment$496,131
R01 · FY2023 · AI · contact PI
Adaptive Immunity and Persistent SARS-CoV-2 Replication$675,412
U01 · FY2022 · CA
Adaptive Immunity and Persistent SARS-CoV-2 Replication$599,569
U01 · FY2022 · CA
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$580,500
R01 · FY2022 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$499,456
R01 · FY2022 · HD · contact PI
Project-002$270,527
U01 · FY2022 · CA
Inflammation and Hearing Loss Following Congenital CMV Infection$617,991
R01 · FY2021 · DC · contact PI
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$580,500
R01 · FY2021 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$498,517
R01 · FY2021 · HD · contact PI
Adaptive Immunity and Persistent SARS-CoV-2 Replication$1,182,648
U01 · FY2020 · CA
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$770,664
R01 · FY2020 · AI · contact PI
Inflammation and Hearing Loss Following Congenital CMV Infection$617,991
R01 · FY2020 · DC · contact PI
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$580,500
R01 · FY2020 · AI · contact PI
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$770,664
R01 · FY2019 · AI · contact PI
Inflammation and Hearing Loss Following Congenital CMV Infection$617,991
R01 · FY2019 · DC · contact PI
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$580,500
R01 · FY2019 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$490,977
R01 · FY2019 · HD · contact PI
Mechanistic Approaches to Inhibition of Emerging DNA Viruses$198,000
R21 · FY2019 · AI
Core C: Vector and Virus Core$176,687
P30 · FY2019 · NS · contact PI
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$770,664
R01 · FY2018 · AI · contact PI
Inflammation and Hearing Loss Following Congenital CMV Infection$617,991
R01 · FY2018 · DC · contact PI
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$592,625
R01 · FY2018 · AI · contact PI
Cytomegalovirus Infection Exacerbates Macrophage-driven Inflammation in Inflammatory Bowel Disease$368,660
R56 · FY2018 · AI
Envelope Assembly of Human Cytomegalovirus$367,500
R01 · FY2018 · AI · contact PI
Core C: Vector and Virus Core$176,687
P30 · FY2018 · NS · contact PI
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$770,664
R01 · FY2017 · AI · contact PI
Inflammation and Hearing Loss Following Congenital CMV Infection$642,241
R01 · FY2017 · DC · contact PI
CMV Vaccines: Reinfection and Antigenic Variation (Natural History of Zika virus excretion in the male genital tract)$422,445
R01 · FY2017 · HD · contact PI
Envelope Assembly of Human Cytomegalovirus$367,500
R01 · FY2017 · AI · contact PI
Core C: Vector and Virus Core$176,687
P30 · FY2017 · NS · contact PI
Identification of pre-fusion conformers of HCMV gB$154,500
R21 · FY2017 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation (Vision and auditory screening in infants born to women enrolled in ZIP)$32,700
R01 · FY2017 · HD · contact PI
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment$779,109
R01 · FY2016 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$468,991
R01 · FY2016 · HD · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$452,670
R01 · FY2016 · HD · contact PI
Envelope Assembly of Human Cytomegalovirus$367,500
R01 · FY2016 · AI · contact PI
Identification of pre-fusion conformers of HCMV gB$203,000
R21 · FY2016 · AI · contact PI
Core C: Vector and Virus Core$176,687
P30 · FY2016 · NS · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$150,000
R01 · FY2016 · HD · contact PI
Inflammation and Hearing Loss Following Congenital CMV Infection$100,000
R56 · FY2016 · DC · contact PI
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$545,519
R01 · FY2015 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$490,017
R01 · FY2015 · HD · contact PI
Envelope Assembly of Human Cytomegalovirus$367,500
R01 · FY2015 · AI · contact PI
PROTEIN INTERACTION CORE$168,690
P30 · FY2015 · NS · contact PI
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$550,305
R01 · FY2014 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$461,543
R01 · FY2014 · HD · contact PI
Envelope Assembly of Human Cytomegalovirus$367,500
R01 · FY2014 · AI · contact PI
MCMV Infection of the Developing CNS: Neuroinvasion and Immune Control$288,040
R01 · FY2014 · NS · contact PI
PROTEIN INTERACTION CORE$173,885
P30 · FY2014 · NS · contact PI
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$522,058
R01 · FY2013 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$450,565
R01 · FY2013 · HD · contact PI
MCMV Infection of the Developing CNS: Neuroinvasion and Immune Control$280,767
R01 · FY2013 · NS · contact PI
PROTEIN INTERACTION CORE$200,240
P30 · FY2013 · NS · contact PI
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$558,373
R01 · FY2012 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$475,154
R01 · FY2012 · HD · contact PI
gM/gN and envelopment of HCMV$319,758
R01 · FY2012 · AI · contact PI
MCMV Infection of the Developing CNS: Neuroinvasion and Immune Control$290,950
R01 · FY2012 · NS · contact PI
PROTEIN INTERACTION CORE$200,412
P30 · FY2012 · NS · contact PI
Congenital CMV and CNS Infection Mechanisms of Protective Immunity$589,230
R01 · FY2011 · AI · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$507,127
R01 · FY2011 · HD · contact PI
gM/gN and envelopment of HCMV$319,758
R01 · FY2011 · AI · contact PI
Envelope Assembly of Human Cytomegalovirus$313,683
R01 · FY2011 · AI · contact PI
MCMV Infection of the Developing CNS: Neuroinvasion and Immune Control$290,950
R01 · FY2011 · NS · contact PI
PROTEIN INTERACTION CORE$205,100
P30 · FY2011 · NS · contact PI
gM/gN and envelopment of HCMV$322,988
R01 · FY2010 · AI · contact PI
Envelope Assembly of Human Cytomegalovirus$316,851
R01 · FY2010 · AI · contact PI
MCMV Infection of the Developing CNS: Neuroinvasion and Immune Control$307,059
R01 · FY2010 · NS · contact PI
gM/gN and envelopment of HCMV$326,250
R01 · FY2009 · AI · contact PI
Envelope Assembly of Human Cytomegalovirus$320,051
R01 · FY2009 · AI · contact PI
Core--Protein interaction$197,066
P30 · FY2009 · NS · contact PI
gM/gN and envelopment of HCMV$326,250
R01 · FY2008 · AI · contact PI
Envelope Assembly of Human Cytomegalovirus$320,051
R01 · FY2008 · AI · contact PI
Core--Protein interaction$128,558
P30 · FY2008 · NS · contact PI
CNS MALDEVELOPMENT AND PERINANTAL INFECTION$249,417
R01 · FY2007 · HD · contact PI
Envelope Assembly of Human Cytomegalovirus$217,500
R01 · FY2007 · AI · contact PI
Core--Protein interaction$128,869
P30 · FY2007 · NS · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$1
R01 · FY2007 · AI · contact PI
gM/gN and Envelopment of HCMV$280,256
R01 · FY2006 · AI · contact PI
CNS MALDEVELOPMENT AND PERINANTAL INFECTION$256,866
R01 · FY2006 · HD · contact PI
Core--Protein interaction$109,998
P30 · FY2006 · NS · contact PI
Congenital CMV in a Highly Seroimmune Maternal Populati*$38,748
R03 · FY2006 · TW · contact PI
CMV Vaccines: Reinfection and Antigenic Variation$1
R01 · FY2006 · AI · contact PI
gM/gN and Envelopment of HCMV$287,000
R01 · FY2005 · AI
CMV Vaccines: Reinfection and Antigenic Variation$287,000
R01 · FY2005 · AI
CNS MALDEVELOPMENT AND PERINANTAL INFECTION$263,048
R01 · FY2005 · HD
Core--Protein interaction$164,061
P30 · FY2005 · NS
Congenital CMV in a Highly Seroimmune Maternal Populati*$39,680
R03 · FY2005 · TW
CMV Vaccines: Reinfection and Antigenic Variation$287,000
R01 · FY2004 · AI
gM/gN and Envelopment of HCMV$287,000
R01 · FY2004 · AI
CNS MALDEVELOPMENT AND PERINANTAL INFECTION$263,048
R01 · FY2004 · HD
ENVELOPE ASSEMBLY OF HUMAN CYTOMEGALOVIRUS$251,125
R01 · FY2004 · AI
Congenital CMV in Highly Seroimmune Maternal Population$39,680
R03 · FY2004 · TW
gM/gN and Envelopment of HCMV$287,000
R01 · FY2003 · AI
CMV Vaccines: Reinfection and Antigenic Variation$287,000
R01 · FY2003 · AI
CNS MALDEVELOPMENT AND PERINANTAL INFECTION$271,058
R01 · FY2003 · HD
ENVELOPE ASSEMBLY OF HUMAN CYTOMEGALOVIRUS$251,125
R01 · FY2003 · AI
gM/gN and Envelopment of HCMV$314,175
R01 · FY2002 · AI
CMV Vaccines: Reinfection and Antigenic Variation$283,955
R01 · FY2002 · AI
ENVELOPE ASSEMBLY OF HUMAN CYTOMEGALOVIRUS$213,456
R01 · FY2002 · AI
IMMUNOLOGICAL CORRELATES OF VACCINE PREVENTION OF CONGENITAL HCMV INFECTION$157,141
P01 · FY2002 · AI
CORE--LABORATORY$157,141
P01 · FY2002 · AI
ENVELOPE ASSEMBLY OF HUMAN CYTOMEGALOVIRUS$247,645
R01 · FY2001 · AI
IMMUNOLOGICAL CORRELATES OF VACCINE PREVENTION OF CONGENITAL HCMV INFECTION$157,141
P01 · FY2001 · AI
CORE--LABORATORY$157,141
P01 · FY2001 · AI
ANTIVIRAL ANTIBODIES AND CNS INFECTION WITH CMV$39,904
R03 · FY2001 · TW
ENVELOPE ASSEMBLY OF HUMAN CYTOMEGALOVIRUS$243,730
R01 · FY2000 · AI
CORE--LABORATORY$184,822
P01 · FY2000 · AI
IMMUNOLOGICAL CORRELATES OF VACCINE PREVENTION OF CONGENITAL HCMV INFECTION$184,822
P01 · FY2000 · AI
ANTIVIRAL ANTIBODIES AND CNS INFECTION WITH CMV$39,904
R03 · FY2000 · TW